Effect of Oral Branched-Chain Amino Acids on Serum Albumin Concentration in Heart Failure Patients with Hypoalbuminemia: Results of a Preliminary Study

Abstract

BackgroundWe conducted a randomized, controlled trial to determine whether supplementation with oral branched-chain amino acids (BCAAs) improves serum albumin and clinical outcomes in heart failure (HF) patients with hypoalbuminemia.Methods and resultsWe randomly assigned 18 in-hospital HF patients with serum albumin < 3.5 g/dL to receive oral BCAA granules (LIVACT®) for 28 days during their hospital stay or until discharge (BCAA group; N = 9) or to receive no supplementation (controls; N = 9), in addition to recommended HF therapy. The primary endpoints were changes from baseline in serum albumin and cardiothoracic ratio (CTR). Sixteen patients completed the study. The mean (± standard deviation) period of BCAA supplementation was 18.4 ± 8.4 days. Serum albumin significantly increased in the BCAA group [mean difference vs baseline, 0.44 g/dL; 95% confidence interval (CI) 0.13–0.76; P = 0.014] and did not change in controls (0.18 g/dL; 95% CI − 0.05 to 0.40; P = 0.108). CTR significantly decreased in the BCAA group (− 2.3%; 95% CI − 3.8 to − 0.8; P = 0.014) and did not change in controls (− 1.0%; 95% CI − 2.3 to 0.3; P = 0.111).ConclusionIn-hospital HF patients with hypoalbuminemia supplemented with BCAAs showed increased serum albumin and decreased CTR.Clinical trial registration number UMIN000004488 [http://www.umin.ac.jp/ctr/index.htm]

Impact of heart failure on functional recovery after hip fracture

“…Recently, several studies have supported the influence of neuromuscular electrical stimulation therapy on improving physical function in HF patients, and its safety also has been confirmed 19 , 20 ) . In addition, other studies have indicated a beneficial impact of branched-chain amino acid (BCAA) supplementation for HF patients 21 , 22 , 23 , 24 ) , and a prospective study is currently being conducted to verify the combined effect of BCAA supplementation during conventional cardiac rehabilitation for Japanese HF patients 25 ) . Although these interventions are not routinely performed during rehabilitation of hip fracture patients, they may potentially be effective even for hip fracture patients with HF.…”

Specific Amino Acids Affect Cardiovascular Diseases and Atherogenesis via Protection against Macrophage Foam Cell Formation: Review Article

“…In line with these findings, a very recent randomized, controlled trial conducted in in-hospital HF-patients demonstrated that supplementation with oral BCAA significantly improved hypoalbuminemia and the cardiothoracic ratio, which are common features of HF condition. 45 Moreover, BCAA treatment preserved cardiac function, prolonged survival, and increased gene expression related to mitochondrial biogenesis and function, in skeletal muscles in a HF-rat model. 46 …”

Actionable Metabolic Pathways in Heart Failure and Cancer—Lessons From Cancer Cell Metabolism

“…For example, branched chain alpha-keto acids are elevated in hearts of heart failure patients, indicating that breakdown of branched chain amino acids (BCAA) is impaired. However, pharmacologic activation of BCAA catabolism and BCAA supplementation increased BCAA oxidation and improved cardiac contractility in heart failure patients and animal models ( 67 , 72 , 73 ). Cachexia is an independent risk factor for mortality during heart failure ( 74 ).…”